<DOC>
	<DOCNO>NCT00935142</DOCNO>
	<brief_summary>The purpose study determine toxicity hypoxia PET-tracer [ 18F ] -VM4-037 cancer patient two dose-steps : - Step 1 ( 3-6 patient ) : single dose maximum 8 mCi ( 296 MBq ) dose [ 18F ] VM4-037 via bolus IV injection . - Step 2 ( 3-6 patient ) : single dose maximum 12 mCi ( 444 MBq ) dose [ 18F ] VM4-037 via bolus IV injection</brief_summary>
	<brief_title>Non-invasive Imaging With 18FVM4-037</brief_title>
	<detailed_description />
	<criteria>Histological cytological confirm solid tumour , primary secondary stage IV and/ tumour curative treatment option WHO performance status 0 1 Normal white blood cell count formula Normal platelet count No anaemia require blood transfusion erythropoietin Adequate hepatic function : Total bilirubin ≤ 1.5 x upper limit normal ( ULN ) institution ; ALT , AST , alkaline phosphatase ≤ 2.5 x ULN institution ) Calculated Creatinin clearance least 60 ml/min No administration Fluor18 previous 24 hour The patient capable comply study procedure 18 year old Only visible tumor sit upper abdomen ( uptake VM4037 liver , stomach kidney would interfere image quality tumor ) Known hypersensitivity sulfonamide Recent ( &lt; 3 month ) myocardial infarction Uncontrolled infectious disease Less 18 year old Pregnancy No concurrent anticancer agent radiotherapy allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>stage IV cancer treatment option</keyword>
	<keyword>non-curative</keyword>
</DOC>